10% Of AIA Petitions Have Been For Pharma, Biologic Patents
Since September 2012, only about 10% of America Invents Act petitions have been targeted at the pharmaceutical and biologic industries, according to new data from the U.S. Patent and Trademark Office....To view the full article, register now.
Already a subscriber? Click here to view full article